157 related articles for article (PubMed ID: 33636699)
1. Resection of primary central nervous system lymphoma: impact of patient selection on overall survival.
Schellekes N; Barbotti A; Abramov Y; Sitt R; Di Meco F; Ram Z; Grossman R
J Neurosurg; 2021 Feb; 135(4):1016-1025. PubMed ID: 33636699
[TBL] [Abstract][Full Text] [Related]
2. Functional Outcome and Overall Survival in Patients with Primary or Secondary CNS Lymphoma after Surgical Resection vs. Biopsy.
Staub-Bartelt F; Rittenauer J; Sabel M; Rapp M
Cancers (Basel); 2023 Nov; 15(21):. PubMed ID: 37958439
[TBL] [Abstract][Full Text] [Related]
3. The role of surgical resection in primary central nervous system lymphoma: a single-center retrospective analysis of 70 patients.
Wu S; Wang J; Liu W; Hu F; Zhao K; Jiang W; Lei T; Shu K
BMC Neurol; 2021 May; 21(1):190. PubMed ID: 33975554
[TBL] [Abstract][Full Text] [Related]
4. [Different treatment regimens for primary central nervous system lymphoma:based on SEER database].
Yang CW; Ren XH; Jiang HH; Li MX; Zhao XZ; Zhu QH; Cui Y; Lin S
Zhonghua Wai Ke Za Zhi; 2021 Jan; 59(1):52-58. PubMed ID: 33412634
[No Abstract] [Full Text] [Related]
5. Whether surgical resection or biopsy makes difference in single lesion primary central nervous system lymphoma: a single center retrospective cohort study.
Cheng X; Chen H; Sun C; Zhang B; Zhang J; Wang Y
BMC Neurol; 2022 Nov; 22(1):411. PubMed ID: 36333683
[TBL] [Abstract][Full Text] [Related]
6. Surgical resection versus biopsy in the treatment of primary central nervous system lymphoma: a systematic review and meta-analysis.
Chojak R; Koźba-Gosztyła M; Polańska K; Rojek M; Chojko A; Bogacz R; Skorupa N; Więcław J; Czapiga B
J Neurooncol; 2022 Dec; 160(3):753-761. PubMed ID: 36449256
[TBL] [Abstract][Full Text] [Related]
7. Resection or Biopsy: The Efficacy of Different Surgical Approaches for Primary Central Nervous System Lymphoma.
Zhang Y; Wang Z; Wang D; Yu B; Wen J; He S; Zeng W; Wang C
Turk Neurosurg; 2024; 34(3):401-406. PubMed ID: 38650554
[TBL] [Abstract][Full Text] [Related]
8. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
9. Resection versus biopsy for management of primary central nervous system lymphoma: a meta-analysis.
Stifano V; Della Pepa GM; Offi M; Montano N; Carcagnì A; Pallini R; Lauretti L; Olivi A; D'Alessandris QG
Neurosurg Rev; 2023 Jan; 46(1):37. PubMed ID: 36645525
[TBL] [Abstract][Full Text] [Related]
10. Clinical Characteristics, Surgical Outcomes, and Prognostic Factors of Intracranial Primary Central Nervous System Lymphoma.
Ouyang T; Wang L; Zhang N; Zhang Z; Xiong Y; Li M; Hong T
World Neurosurg; 2020 Jul; 139():e508-e516. PubMed ID: 32311566
[TBL] [Abstract][Full Text] [Related]
11. Craniotomy and Survival for Primary Central Nervous System Lymphoma.
Rae AI; Mehta A; Cloney M; Kinslow CJ; Wang TJC; Bhagat G; Canoll PD; Zanazzi GJ; Sisti MB; Sheth SA; Connolly ES; McKhann GM; Bruce JN; Iwamoto FM; Sonabend AM
Neurosurgery; 2019 Apr; 84(4):935-944. PubMed ID: 29660011
[TBL] [Abstract][Full Text] [Related]
12. The safety of resection for primary central nervous system lymphoma: a single institution retrospective analysis.
Cloney MB; Sonabend AM; Yun J; Yang J; Iwamoto F; Singh S; Bhagat G; Canoll P; Zanazzi G; Bruce JN; Sisti M; Sheth S; Connolly ES; McKhann G
J Neurooncol; 2017 Mar; 132(1):189-197. PubMed ID: 28116650
[TBL] [Abstract][Full Text] [Related]
13. Surgical Resection for Primary Central Nervous System Lymphoma: A Systematic Review.
Labak CM; Holdhoff M; Bettegowda C; Gallia GL; Lim M; Weingart JD; Mukherjee D
World Neurosurg; 2019 Jun; 126():e1436-e1448. PubMed ID: 30904794
[TBL] [Abstract][Full Text] [Related]
14. The role of surgery in intracranial PCNSL.
Jahr G; Da Broi M; Holte H; Beiske K; Meling TR
Neurosurg Rev; 2018 Oct; 41(4):1037-1044. PubMed ID: 29383600
[TBL] [Abstract][Full Text] [Related]
15. The role of comorbidity indices and histochemical markers in surgically resected and non-resected primary central nervous system lymphoma.
Wong CE; Liao WA; Chang Y; Lee PH; Huang CC; Chang KC; Lee JS
Clin Exp Med; 2023 Nov; 23(7):3799-3807. PubMed ID: 37491648
[TBL] [Abstract][Full Text] [Related]
16. Role of chemotherapy additional to high-dose methotrexate for primary central nervous system lymphoma (PCNSL).
Bergner N; Monsef I; Illerhaus G; Engert A; Skoetz N
Cochrane Database Syst Rev; 2012 Nov; 11():CD009355. PubMed ID: 23152274
[TBL] [Abstract][Full Text] [Related]
17. Hemorrhagic Attitude in Frameless and Frame-Based Stereotactic Biopsy for Deep-Seated Primary Central Nervous System Lymphomas in Immunocompetent Patients: A Multicentric Analysis of the Last Twenty Years.
Callovini GM; Sherkat S; Sperduti I; Crispo F; Raus L; Gazzeri R; Telera S
World Neurosurg; 2021 May; 149():e1017-e1025. PubMed ID: 33476784
[TBL] [Abstract][Full Text] [Related]
18. Glioblastoma in the elderly: the effect of aggressive and modern therapies on survival.
Babu R; Komisarow JM; Agarwal VJ; Rahimpour S; Iyer A; Britt D; Karikari IO; Grossi PM; Thomas S; Friedman AH; Adamson C
J Neurosurg; 2016 Apr; 124(4):998-1007. PubMed ID: 26452121
[TBL] [Abstract][Full Text] [Related]
19. Surgery plus adjuvant radiotherapy for primary central nervous system lymphoma.
Kinslow CJ; Rae AI; Neugut AI; Adams CM; Cheng SK; Sheth SA; McKhann GM; Sisti MB; Bruce JN; Iwamoto FM; Sonabend AM; Wang TJC
Br J Neurosurg; 2020 Dec; 34(6):690-696. PubMed ID: 31931632
[No Abstract] [Full Text] [Related]
20. Prognostic impact of peripheral natural killer cells in primary central nervous system lymphoma.
Lin Z; Ma J; Ma Y; Li Q; Kang H; Zhang M; Chen B; Xia R
Front Immunol; 2023; 14():1191033. PubMed ID: 37426647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]